Temasek, Yunfeng lead $75 million funding into China genomics firm: Reuters

Jack Ma's private equity firm Yunfeng Capital and Singapore's Temasek have led a $75 million fund-raising round into genomics company WuXi NextCODE, the firm said in a statement on Tuesday, underlining a race for medical data in China.

DealsNorth AmericaUSBriefs